Cross Cancer Institute /ID# 132883

Edmonton, Alberta T6G 1Z2

0 studies enrolling now · 1 studies all time

What they study most

Small Cell Lung Cancer

Studies at this site

• Dose Escalation and Double-blind Study of Veliparib in Combination With Carboplatin and Etoposide in Treatment-naive Extensive Stage Disease Small Cell Lung Cancer — Completed